Treatment delays in children and young adults with lymphoma: a report from an East Africa lymphoma cohort study
Open Access
- 25 August 2023
- journal article
- letter
- Published by American Society of Hematology in Blood Advances
- Vol. 7 (17) , 4962-4965
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic settingBMC Cancer, 2019
- Pathogenesis of lymphomas2017
- Beyond Endemic Burkitt Lymphoma: Navigating Challenges of Differentiating Childhood Lymphoma Diagnoses Amid Limitations in Pathology Resources in Lilongwe, MalawiGlobal Pediatric Health, 2017
- Outcomes for paediatric Burkitt lymphoma treated with anthracycline‐based therapy in MalawiBritish Journal of Haematology, 2016
- Predictors of delay in diagnosis and treatment in diffuse large B‐cell lymphoma and impact on survivalBritish Journal of Haematology, 2014
- Burkitt lymphoma research in East Africa: highlights from the 9th African organization for research and training in cancer conference held in Durban, South Africa in 2013Infectious Agents and Cancer, 2014
- Factors influencing time to diagnosis and initiation of treatment of endemic Burkitt Lymphoma among children in Uganda and western Kenya: a cross-sectional surveyInfectious Agents and Cancer, 2013
- Treatment of cancer in sub-Saharan AfricaThe Lancet Oncology, 2013
- Treatment of Burkitt lymphoma in equatorial Africa using a simple three‐drug combination followed by a salvage regimen for patients with persistent or recurrent diseaseBritish Journal of Haematology, 2012
- Lymphomas in sub‐Saharan Africa – what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?British Journal of Haematology, 2011